Skip to content
Review

Abstract 13895: Comparison of Left Atrial Appendage Closure Devices with Oral Anticoagulation Therapy on Clinical Outcomes in Patients with Atrial Fibrillation: A Reconstructed Individual-Patient Data Meta-Analysis

Nov 2026 · Circulation · 0 citations

Abstract

Background: Oral anticoagulation (OAC) remains the cornerstone of stroke prevention in atrial fibrillation (AF), but its use is limited by bleeding risk. Left atrial appendage occlusion (LAAO) devices offer a nonpharmacological alternative; however, recent randomized trials have reported inconsistent efficacy compared with OAC. Research question: To compare the safety and efficacy of LAAO and OAC in adults with AF. Methods: We searched MEDLINE, EMBASE, and Cochrane CENTRAL to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) through April 1, 2026. We included adult patients (≥18 years) with all subtypes of AF on OAC or LAAO devices. Primary outcome was ischemic stroke; secondary outcomes included major bleeding, hemorrhagic stroke, and all-cause mortality. We pooled aggregate data using risk ratios (RR) with 95% CIs; random-effects models were applied when heterogeneity was substantial (I 2 >60%). As a sensitivity analysis, individual patient-level data (IPD) were reconstructed from published Kaplan-Meier curves and analyzed as time-to-event outcomes (hazard ratios, HR). Results: Among six included RCTs (total n= 7,004), the weighted mean age was 72 years, CHA 2 DS 2 -VASc score 3.9, HAS-BLED score 1.7, and follow-up duration 38 months. Aggregate analysis showed no significant difference in ischemic stroke (RR 1.21, 95% CI 0.83-1.78), major bleeding (RR 0.74, 95% CI 0.50-1.10), or all-cause mortality (RR 0.89, 95% CI 0.66-1.21). LAAO was associated with a significantly lower risk of hemorrhagic stroke (RR 0.23, 95% CI 0.07-0.74). Reconstructed IPD from available trials demonstrated no significant differences in all-stroke (3 studies; HR 1.24, 95% CI 0.79-1.94) or major bleeding (2 studies; HR 0.84, 95% CI 0.65-1.07), while showing lower all-cause mortality with LAAO (2 studies; HR 0.70, 95% CI 0.52-0.95). Conclusion: LAAO provided similar protection against ischemic stroke and reduced the risk of hemorrhagic stroke compared with OAC. Reconstructed IPD suggested a potential mortality benefit, although evidence was limited by the small number of contributing trials. Further studies with contemporary devices and post-ablation populations are needed.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.